Squarepoint
IDXX icon

Squarepoint’s Idexx Laboratories IDXX Stock Holding History

Squarepoint’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$684K Buy
+1,300
New +$729K ﹤0.01% 3184
2025
Q4 		– Sell
-5,000
Closed -$3.19M – 4540
2025
Q3 		$3.19M Buy
5,000
+3,100
+163% +$1.88M ﹤0.01% 1739
2025
Q2 		$1.02M Buy
+1,900
New +$909K ﹤0.01% 2639
2024
Q3 		– Sell
-800
Closed -$390K – 4359
2024
Q2 		$390K Sell
800
-1,400
-64% -$703K ﹤0.01% 3255
2024
Q1 		$1.19M Buy
+2,200
New +$1.2M ﹤0.01% 2468

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Squarepoint's IDXX Position: Q2 2026 in Review

Squarepoint increased its Idexx Laboratories (IDXX) stake by 214% in Q2 2026, buying an estimated $121M and bringing the position to 315,164 shares worth $166M. The position accounts for 0.18% of the portfolio, ranked #92.

Squarepoint first reported a position in IDXX in Q1 2015 and has held it in 35 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Squarepoint held 315,164 shares of Idexx Laboratories worth $166M as of Q2 2026.
  • Squarepoint bought 214,855 Idexx Laboratories shares in Q2 2026, an estimated $121M.
  • Idexx Laboratories made up 0.18% of Squarepoint's portfolio in Q2 2026, its #92 holding.
  • Squarepoint first reported a position in Idexx Laboratories in Q1 2015 and has held it in 35 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.